Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003.

Saved in:
Bibliographic Details
Title: Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003.
Authors: Gondi V; Northwestern University Feinberg School of Medicine, Chicago, IL., Pugh SL; NRG Oncology Statistics and Data Management Center, Philadelphia, PA.; American College of Radiology, Philadelphia, PA., Mehta MP; Miami Cancer Institute, Miami, FL., Wefel JS; University of Texas MD Anderson Cancer Center, Houston, TX., Tomé WA; Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY., Sun AY; University Health Network-Princess Margaret Hospital, Toronto, Canada., Grecula J; Ohio State University Comprehensive Cancer Center, Columbus, OH., Redmond KJ; The Johns Hopkins University School of Medicine, Baltimore, MD., Fogh S; UCSF Medical Center-Parnassus, San Francisco, CA., Gaspar L; University of Colorado, Denver, CO., Konski A; Chester County Hospital, West Chester, PA., Bovi J; ThedaCare Regional Hospital, Appleton, WI., Robinson CG; Siteman Cancer Center at Washington University, St. Louis, MO., Corn B; Shaare Zedek Medical Center, Jerusalem, Israel., Videtic GM; Cleveland Clinic Foundation, Cleveland, OH., Lok BH; University Health Network-Princess Margaret Hospital, Toronto, Canada., Yoon HA; Heartland NCORP, Decatur, IL., Heinzerling JH; Atrium Health/Levine Cancer Institute/Wake Forest University School of Medicine, Charlotte, NC., DeNittis AS; Lankenau Medical Center, Wynnewood, PA., McGarry RC; University of Kentucky, Lexington, KY., Devisetty K; Karmanos Cancer Institute/Wayne State University, Detroit, MI., Kundapur V; Saskatoon Cancer Centre, Saskatoon, Canada., Wu AJ; Memorial Sloan Kettering Cancer Center, New York, NY., McCarron EC; MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore, MD., Thibault I; CHU de Quebec-Université Laval, Quebec, Canada., Simon EL; Georgia NCI Community Oncology Research Program, Cumming, GA., Baschnagel AM; University of Wisconsin Carbone Cancer Center, Madison, WI., Narayan S; Michigan Cancer Research Consortium NCORP, Ypsilanti, MI., Pollock J; West Virginia University Healthcare, Wheeling, WV., Paulus R; NRG Oncology Statistics and Data Management Center, Philadelphia, PA.; American College of Radiology, Philadelphia, PA., Kachnic LA; Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, MU-NCORP, New York, NY.
Corporate Authors: NRG Oncology
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Nov 10; Vol. 43 (32), pp. 3516-3525. Date of Electronic Publication: 2025 Aug 11.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Equivalence Trial
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO-25-00221